India set to become global leader in APIs industry

Low-cost manufacturing facilities and abundant talent pool will drive the growth of India in the global active pharmaceutical ingredients (APIs) market, says RNCOS in its latest research study, titled Global API Market Analysis. This shows that India has been attracting the attention of the global players in the international APIs market.

Owing to a large number of products going off-patent in developed markets, pressure to contain rising health care costs, intensifying competition and a shift to the networked pharmaceutical operating model, the Indian APIs market is expected to witness stupendous growth rates in the coming years, says RNCOS.

The study indicates that the key strategies for future growth for companies include the manufacturing of non-antibiotic ranges of APIs, entering into the contract research and manufacturing (CRAMS) segment with a focus on partnering with innovator companies and increased penetration in regulated markets, where margins are significantly higher.